Vice Chairman: Ms. Nisa Wing-Yu LEUNG

Nisa Leung is a Managing Partner of Qiming Ventures leading its health care investments. Qiming manages USD 1.3 Billion and is one of the most active funds in China. It has won numerous awards including most recently TOP 50 GP with the most investment potential in China at Top Capital Summit in 2012, Top 10 China Foreign VC Funds by Zero2IPO and Top 10 Bio/Healthcare VC/PE Firm in China in 2012 and Top 10 Value-added Service VC/PE firms of the year 2012.

Nisa currently sits on the board of Gan & Lee Pharmaceutical Co. Ltd, Crown Bioscience, Novast Pharmaceuticals, Nurotron, Venus MedTech, Origene Technologies, Goodwill Information Technology, Sangon Biotech, Aeonmed Medical (observer), Biomedic Holdings and related companies. Nisa also represented Qiming on other health care investments including Alltech Medical, CITIC Pharmaceuticals (acquired by Shanghai Pharmaceutical HKSE: 02607) and Guokang.

Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She currently serves on the Board of Governors of the Hotchkiss School, is member of Cornell Life Sciences Advisory Board, director of Young Entrepreneur Development Council and director of Hong Kong Science and Technology Parks Corporation.


Free Joomla! template by Age Themes